We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.16B
1-Year Est. Return 67.93%
This Fund
S&P 500
This Quarter Est. Return
-18.07%
1 Year Est. Return
+67.93%
3 Year Est. Return
-39.17%
5 Year Est. Return
-45.89%
10 Year Est. Return
–
AUM
$394M
AUM Growth
+$95.3M
Cap. Flow
+$192M
Cap. Flow %
48.62%
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$160M
2
QTRX icon
Quanterix
QTRX
+$39.6M

Top Sells

Rank Stock Value
1
TTOO
T2 Biosystems, Inc
TTOO
+$8.19M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNLI icon
1
Denali Therapeutics
DNLI
$3.67B
$139M 35.37%
+8,918,749
New +$160M
MCRB icon
2
Seres Therapeutics
MCRB
$48.1M
$129M 32.61%
634,144
– –
EDIT icon
3
Editas Medicine
EDIT
$399M
$51.5M 13.05%
1,674,435
– –
QTRX icon
4
Quanterix
QTRX
$173M
$43.6M 11.06%
+2,030,495
New +$39.6M
SYRS
5
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$31.2M 7.91%
320,444
– –
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
– –
-390
Closed -$8.19M

Similar funds

AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
BI
Bramshill Investments Naples, Florida $1.16B AUM 0.86% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $1.16B AUM 13.88% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
FFP
FourThought Financial Partners Venice, Florida $1.16B AUM 24.95% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Flagship Pioneering's Q4 2017 Portfolio in Review

As of Q4 2017, Flagship Pioneering held 6 positions worth $394M, up 32% from $299M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering deployed $192M of net new capital in Q4 2017, opening 2 new positions. Its largest new stake was Denali Therapeutics: 8,918,749 shares worth $139M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier.

On the sell side, the most notable exit was T2 Biosystems, Inc, an estimated $8.19M sold.

  • Flagship Pioneering's largest Q4 2017 buy was Denali Therapeutics: 8,918,749 shares worth $139M.
  • Flagship Pioneering fully exited T2 Biosystems, Inc in Q4 2017, selling an estimated $8.19M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $394M portfolio in Q4 2017.
  • Flagship Pioneering opened 2 new positions and closed 1 in Q4 2017.
  • Flagship Pioneering's portfolio value rose 32% quarter-over-quarter to $394M.

Based on Flagship Pioneering's 13F filing for Q4 2017, filed 14 Feb 2018.